Gene expression and functional studies have indicated that the molecular programmes in-volved in prostate development are also active in prostate cancer. PTEN has been implicat-ed in human prostate cancer and is frequently mutated in this disease. Here, using the Nkx3.1:Cremouse strain and a genetic deletion approach, we investigate the role of Pten specifically in the developing mouse prostate epithelia. In contrast to its role in other devel-oping organs, this gene is dispensable for the initial developmental processes such as bud-ding and branching. However, as cytodifferentiation progresses, abnormal luminal cells fill the ductal lumens together with augmented epithelial proliferation. This phenotype resem-bles the hyperplasia seen in p...
PTEN deficiency predisposes to a subset of human cancers, but the mechanism that underlies such sele...
<div><p>Prostate cancer is a major cause of male death in the Western world, but few frequent geneti...
PTEN and TP53 loss are common molecular alterations in aggressive prostate cancer that progresses to...
Gene expression and functional studies have indicated that the molecular programmes involved in pros...
<div><p>Gene expression and functional studies have indicated that the molecular programmes involved...
Abstract PTEN is one of the most commonly deleted/mutated tumor suppressor genes in human prostate c...
The PSA-Cre;Pten-loxP/loxP mouse prostate cancer model displays clearly defined stages of hyperplasi...
The PSA-Cre;Pten-loxP/loxP mouse prostate cancer model displays clearly defined stages of hyperplasi...
PTEN mutations are among the most frequent genetic alterations found in human prostate cancers. Our ...
PTEN is one of the most commonly deleted tumor suppressor genes in human prostate cancer. Our group ...
The PSA-Cre;Pten-loxP/loxP mouse prostate cancer model displays clearly defined stages of hyperplasi...
AbstractThe murine Pten prostate cancer model described in this study recapitulates the disease prog...
Although androgen deprivation therapy is a widely used treatment for patients with advanced prostate...
Knowledge gained from the identification of genetic and epigenetic alterations that contribute to th...
<p>(A) brightfield images of mouse prostates with epithelial <i>Pten</i> deletion and stabilized β-C...
PTEN deficiency predisposes to a subset of human cancers, but the mechanism that underlies such sele...
<div><p>Prostate cancer is a major cause of male death in the Western world, but few frequent geneti...
PTEN and TP53 loss are common molecular alterations in aggressive prostate cancer that progresses to...
Gene expression and functional studies have indicated that the molecular programmes involved in pros...
<div><p>Gene expression and functional studies have indicated that the molecular programmes involved...
Abstract PTEN is one of the most commonly deleted/mutated tumor suppressor genes in human prostate c...
The PSA-Cre;Pten-loxP/loxP mouse prostate cancer model displays clearly defined stages of hyperplasi...
The PSA-Cre;Pten-loxP/loxP mouse prostate cancer model displays clearly defined stages of hyperplasi...
PTEN mutations are among the most frequent genetic alterations found in human prostate cancers. Our ...
PTEN is one of the most commonly deleted tumor suppressor genes in human prostate cancer. Our group ...
The PSA-Cre;Pten-loxP/loxP mouse prostate cancer model displays clearly defined stages of hyperplasi...
AbstractThe murine Pten prostate cancer model described in this study recapitulates the disease prog...
Although androgen deprivation therapy is a widely used treatment for patients with advanced prostate...
Knowledge gained from the identification of genetic and epigenetic alterations that contribute to th...
<p>(A) brightfield images of mouse prostates with epithelial <i>Pten</i> deletion and stabilized β-C...
PTEN deficiency predisposes to a subset of human cancers, but the mechanism that underlies such sele...
<div><p>Prostate cancer is a major cause of male death in the Western world, but few frequent geneti...
PTEN and TP53 loss are common molecular alterations in aggressive prostate cancer that progresses to...